BIVI
BIOVIE INC.
NASDAQ · Healthcare · Biotechnology · US
$1.37
+14.17%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.70
- EPS estimate
- -$0.52
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +17.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.52 | -$0.70 | Miss -34.62% | — |
| May 11, 2026 | -$0.73 | -$0.70 | Beat 4.11% | — |
| Feb 6, 2026 | -$0.81 | -$0.77 | Beat 4.94% | — |
| Aug 15, 2025 | -$4.40 | -$0.24 | Beat 94.63% | — |
| Sep 30, 2024 | -$15 | -$66 | Miss -340.00% | — |
| Feb 12, 2024 | -$32 | -$22 | Beat 31.25% | — |
| Aug 16, 2023 | -$37 | -$23 | Beat 37.84% | — |
| May 12, 2023 | -$0.35 | -$43 | Miss -12185.71% | — |
| Feb 10, 2023 | -$0.25 | -$50 | Miss -19900.00% | — |
| Nov 4, 2022 | -$0.28 | -$38 | Miss -13471.43% | — |
| May 11, 2022 | -$0.42 | -$0.28 | Beat 33.33% | — |
| Feb 8, 2022 | -$0.31 | -$0.28 | Beat 9.68% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026